Estradiol induction of cAMP in breast cancer cells is mediated by foetal calf serum (FCS) and sex hormone-binding globulin (SHBG)

被引:33
|
作者
Fortunati, N
Fissore, F
Fazzari, A
Piovano, F
Catalano, MG
Becchis, M
Berta, L
Frairia, R
机构
[1] Univ Turin, Lab Endocrinol, UOADU Med Gen 2, Azienda Osped S Giovanii Bta, I-10126 Turin, Italy
[2] Univ Turin, Dipartimento Fisiopatol Clin, I-10126 Turin, Italy
关键词
D O I
10.1016/S0960-0760(99)00092-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Plasma sex hormone-binding globulin (SHBG or SEP), the specific carrier for estradiol and androgens, after binding to its membrane receptor (SHBG-R), causes a significant increase of cAMP in the presence of estradiol, in both breast (MCF-7) and prostate (LNCaP) cancer cells maintained in serum-free medium. On the other hand, it has been proposed that estrogens, in addition to the well-known nuclear receptor pathway, exert their biological effect inducing cAMP, as a consequence of a direct membrane action, in breast cancer and uterine cells. The aim of the present study was to clarify this controversial issue by verifying if the cAMP increase in MCF-7 cells was a direct effect of estradiol, or if it was mediated by FCS proteins, such as bovine sex hormone-binding globulin; and to reevaluate the effect of human SHBG on cAMP induction in the presence of FCS. MCF-7 cells were maintained in DCC-FCS (treated with DCC to remove steroids), in SHBG-FREE/DCC-FCS (treated with DCC and with a specific affinity chromatography to remove bovine sex hormone-binding globulin), or in serum-free medium (SFM). It was observed that estradiol determined a significant time-dependent increase of cAMP only in MCF-7 cells maintained in 10% DCC-FCS. When cells were maintained in 10% SHBG-FREE/DCC-FCS, estradiol had no detectable effect. However, its ability to increase cAMP was observed again after the addition of human SHBG, in doses ranging from 5 to 50 nM. Moreover, in the presence of 10% SHBG-FREE/DCC-FCS, SHBG, even in the absence of estradiol, caused a significant increase of cAMP. In conclusion, the data reported in the present study suggest that the ability of estradiol to induce cAMP in MCF-7 cells is not due to a direct membrane effect of the hormone, but rather it is mediated by FCS. SHBG is one of the serum factors mediating estradiol action. Lastly, it was proven that SHBG triggers the cAMP pathway in MCF-7 cells in a physiologic culture condition and at physiologic concentrations. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:73 / 80
页数:8
相关论文
共 50 条
  • [21] Effects of sex hormone-binding globulin (SHBG) on androgen bioactivity in vitro
    Laurent, Michael R.
    Helsen, Christine
    Antonio, Leen
    Schollaert, Dieter
    Joniau, Steven
    Vos, Michel J.
    Decallonne, Brigitte
    Hammond, Geoffrey L.
    Vanderschueren, Dirk
    Claessens, Frank
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2016, 437 (0C) : 280 - 291
  • [22] AN ENZYME-IMMUNOASSAY FOR HUMAN SEX HORMONE-BINDING GLOBULIN (SHBG)
    HEUBNER, A
    RUDE, S
    JUCHEM, M
    POLLOW, K
    ACTA ENDOCRINOLOGICA, 1987, 114 : 139 - 139
  • [23] Immunohistochemical and in-situ detection of sex hormone-binding globulin (SHBG) expression in breast and prostate cancer:: Implications for hormone regulation
    Kahn, SM
    Hryb, DJ
    Nakhla, AM
    Khan, SM
    Romas, NA
    Rosner, W
    HORMONAL CARCINOGENESIS IV, 2005, : 508 - 514
  • [24] COMPETITIVE LIGAND-BINDING ASSAY FOR MEASUREMENT OF SEX HORMONE-BINDING GLOBULIN (SHBG)
    TULCHINSKY, D
    CHOPRA, IJ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1973, 37 (06): : 873 - 881
  • [25] The additionally glycosylated variant of human sex hormone-binding globulin (SHBG) is linked to estrogen-dependence of breast cancer
    Becchis, M
    Frairia, R
    Ferrera, P
    Fazzari, A
    Ondei, S
    Alfarano, A
    Coluccia, C
    Biglia, N
    Sismondi, P
    Fortunati, N
    BREAST CANCER RESEARCH AND TREATMENT, 1999, 54 (02) : 101 - 107
  • [26] Obesity and Sex Hormone-Binding Globulin (SHBG) Levels in Gestational Diabetes.
    Morisset, A. S.
    Dube, M. C.
    Drolet, R.
    Nadeau, M.
    Robitaille, J.
    Weisnagel, S. J.
    Tchernof, A.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [27] Sex hormone-binding globulin (SHBG) as a predictor of the metabolic syndrome (MS) in men
    Tsai, EC
    Matsumoto, AM
    Fujimoto, WY
    Boyko, EJ
    DIABETES, 2004, 53 : A257 - A257
  • [28] Evaluation of a new automated electrochemiluminescent sex hormone-binding globulin (SHBG) immunoassay
    Reynders, M
    Anckaert, E
    Schiettecatte, J
    Smitz, J
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2005, 43 (01) : 86 - 89
  • [29] SEX HORMONE-BINDING GLOBULIN (SHBG) AND ANDROGEN LEVELS IN WOMEN WITH ANDROGENETIC ALOPECIA
    SINNECKER, G
    LUDWIG, E
    KRENZ, A
    WILLIG, RP
    ACTA ENDOCRINOLOGICA, 1987, 114 : 144 - 144
  • [30] The relationship of sex hormone-binding globulin (SHBG) gene polymorphisms with serum SHBG level and metabolic syndrome in Chinese Han males
    Xiao-Na Pang
    Ying Yuan
    Yan Sun
    Ji-Ping Shen
    Xiao-Yun Zha
    Yu Hu
    Aging Clinical and Experimental Research, 2014, 26 : 583 - 589